NCT02691156View on ClinicalTrials.gov

Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants

CompletedOBSERVATIONAL
Enrollment

143

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Bilirubin-induced Neurologic DysfunctionHyperbilirubinemiaKernicterusInfant, PrematureInfant, Low Birth Weight
Interventions
DIAGNOSTIC_TEST

Bilirubin Binding Capacity

Research laboratory assay of bilirubin binding capacity

DIAGNOSTIC_TEST

End-tidal Carbon Monoxide

Noninvasive bedside test to measure exhaled end-tidal carbon monoxide levels for the detection of hemolysis

DIAGNOSTIC_TEST

Carboxyhemoglobin

Laboratory assay of carboxyhemoglobin levels for the detection of hemolysis

Trial Locations (1)

94305

Lucile-Packard Children's Hospital at Stanford, Stanford

All Listed Sponsors
collaborator

Smith-Kettlewell Eye Research Institute

OTHER

lead

Stanford University

OTHER

NCT02691156 - Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants | Biotech Hunter | Biotech Hunter